![Carol Ashe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Carol G.
Ashe currently works at Elicio Therapeutics, Inc. (United States), as Independent Director from 2020, Elicio Therapeutics, Inc., as Independent Director from 2020, and New York Genome Center, as Chief Business Officer from 2014.
Ms. Ashe also formerly worked at Aptose Biosciences, Inc., as Independent Director from 2018 to 2025, Endo International Plc, as Vice President-Corporate Development from 2011 to 2013, GSK Equity Investments Ltd, as Partner from 2009 to 2010, and GSK Plc, as Head-US Corporate Legal Group from 2007 to 2008.
Ms. Ashe received her undergraduate degree from The Pennsylvania State University and graduate degree from Villanova University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/08/2020 |
New York Genome Center
 New York Genome Center Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Corporate Officer/Principal | 01/01/2014 |
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Director/Miembro de la Junta | 01/01/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| APTOSE BIOSCIENCES INC. | Director/Miembro de la Junta | 16/06/2025 |
| ENDO INTERNATIONAL PLC | Corporate Officer/Principal | 01/01/2013 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Inversor de Capital Privado | 30/03/2010 |
| GSK PLC | Corporate Officer/Principal | 01/01/2008 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Commercial Services |
Villanova University School of Law
 Villanova University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
